Hematological diseases serve as a vital "experimental field" for the development of new drugs and treatment methods. Many innovative therapies are rooted in hematology research, with advanced technologies such as tumor-targeted therapy, cell immunotherapy, and gene therapy all originating from the treatment of hematological conditions. The Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS), was the first specialty hospital in China dedicated to both patient care and scientific research in hematology, serving as an educational center for hematologists across the country. Over the years, IHCAMS has conducted the most clinical trials of new drugs for hematological diseases in China. Notably, there are many ongoing trials on cell and gene therapy products at our hospital. The first CAR-T product for refractory adult B-ALL developed at IHCAMS was approved for the market in China in 2023. With the official inauguration of the new medical center at IHCAMS in September 2023, it has become the largest treatment center for blood diseases in the world, featuring 14 clinical centers and 1,500 beds covering both pediatric and adult hematology. IHCAMS has consistently ranked as the top specialty hospital for both clinical care and scientific impact in hematology in China for the past 14 and 11 years, respectively. The International Workshop on Cell Therapy of Blood Diseases hosted by IHCAMS and supported by the Ministry of Science and Technology of the People's Republic of China, aims to provide fundamental, clinical, and translational courses for junior researchers and physicians across the Belt and Road countries. The traineeship offers a two-week program covering courses in cellular therapy and gene therapy for hematologic diseases such as hematologic malignancies and thalassemia, immunotherapies for hematologic and other diseases, and spatial-temporal omics in blood disease research.
Guideline for Application:
- Qualifications for Application: Researchers or physicians holding either a Ph.D. or an M.D. degree who are currently employed by professional institutions in the Belt and Road countries.
- Application Due Date: Monday, May 12, 2025, 11:59 p.m. GMT
- List of Notice of Admission: May 30, 2025
- Program Start Date: August 17, 2025
- Language: English
- Supporting Documents: 1. Complete personal CV; 2. Proof of professional qualifications; 3. Photocopy of travel documents; 4. Supporting letter from the employer. Please include all the required documents and email to: xcwang@ihcams.ac.cn.
- Fees: The workshop will cover training expenses and accommodation for trainees during their stay in Tianjin, China, from August 17 to September 1, 2025. Please note that trainees will be responsible for their travel expenses and any costs NOT mentioned above.
Program:
|
Date |
Session Topic |
Speaker |
Venue |
|
Sun, Aug 17, 2025 |
All-day: Registration |
Hotel |
|
|
Mon, Aug 18, 2025 |
Morning: Opening Ceremony |
Cheng Tao |
Tuanbo Campus |
|
Stem Cell Basic Research and Clinical Applications |
Cheng Tao |
Tuanbo Campus |
|
|
Afternoon: Overview of Immunotherapy for Hematologic Malignancies |
Wang Jianxiang |
Tuanbo Campus |
|
|
Tue, Aug 19, 2025 |
Morning: Overview of Hematopoietic Stem Cell Transplantation (HSCT) |
TBD |
Tuanbo Campus |
|
Stem Cell Mobilization & Collection |
TBD |
Tuanbo Campus |
|
|
Afternoon: Tour of Apheresis Unit (Transfusion Center) |
Li Qiang |
Tuanbo Campus |
|
|
Wed, Aug 20, 2025 |
Morning: Management of Transplant Complications |
Feng Sizhou |
Tuanbo Campus |
|
Prevention and Treatment of Post-Transplant Relapse |
Pang Aiming |
Tuanbo Campus |
|
|
Afternoon: Tour of Cord Blood Bank and Transplant Center |
|
Huayuan Campus |
|
|
Thu, Aug 21, 2025 |
Morning: Tour of Cell Ecology Haihe Laboratory |
Zhang Yingchi |
Haihe Lab |
|
Afternoon: Cell Preparation and Quality Control in GMP Facilities |
TBD |
Haihe Lab |
|
|
Fri, Aug 22, 2025 |
Morning: Clinical Applications of Mesenchymal Stem Cells |
TBD |
Tuanbo Campus |
|
Overview of iPS Cell Research |
TBD |
Tuanbo Campus |
|
|
Afternoon: CAR T Applications in Autoimmunity and Transplantation |
VJ |
Tuanbo Campus |
|
|
Sat-Sun, Aug 23-24 |
Weekend Break |
|
|
|
Mon, Aug 25, 2025 |
Morning: Advances in Immunotherapy for Acute Lymphoblastic Leukemia |
TBD |
Tuanbo Campus |
|
Advances in Immunotherapy for Multiple Myeloma |
TBD |
Tuanbo Campus |
|
|
Afternoon: Advances in Immunotherapy for Lymphoma |
TBD |
Tuanbo Campus |
|
|
Tue, Aug 26, 2025 |
Morning: CAR-T Cell Manufacturing |
Wang Yongzeng (Juventas Cell Therapy Ltd.) |
Tuanbo Campus |
|
Afternoon: Visit to Juventas Cell Therapy Ltd. |
Juventas Cell Therapy Ltd. |
Juventas Cell Therapy Ltd. |
|
|
Wed, Aug 27, 2025 |
Morning: AAV Vector-Based Gene Therapy for Hemophilia B |
Xiao Xiao (Belief Biomed) |
Tuanbo Campus |
|
Case Study |
TBD |
Tuanbo Campus |
|
|
Afternoon: Preparation of AAV Gene Therapy |
Zheng Jing |
Tuanbo Campus |
|
|
Thu, Aug 28, 2025 |
Morning: Gene Therapy for Thalassemia |
Kanglin Biotec |
Tuanbo Campus |
|
CAR T-Cell Therapy for Autoimmune Hemolytic Anemia (AIHA) |
Li Ruonan |
Tuanbo Campus |
|
|
Afternoon: Group Discussion |
Tuanbo Campus |
||
|
Fri, Aug 29, 2025 |
Morning: Accelerating Translational Research: From Bench to Industry |
Zhang Yu |
Haiguang Campus |
|
Group Discussion |
|
|
|
|
Afternoon: Tour of Hospital History Museum Tour of Diagnostics Platform |
Organizing Committee/ Pathology Center |
Haiguang Campus |
|
|
Sat-Sun, Aug 30-31 |
Weekend Break |
|
|
|
Mon, Sep 1, 2025 |
Afternoon: Closing Ceremony |
Haiguang Campus |
Venue:
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tuanbo Campus
28 Tuanbo Road, Jinghai, Tianjin, China
Accommodation：
lia! by minyoun perennial tianjin
B Zone, No.18 Liujing Road, Xiqing District, Tianjin, China
Contact:
Should you have any questions, please feel free to contact the Dr. Xiaochen Wang, by phone (86-22-23909681) or via email: xcwang@ihcams.ac.cn.